The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Reduced Glutathione (GSH) Drugs Market Research Report 2025
Synopsis
Reduced glutathione is a peptide naturally synthesized in human cytoplasm, composed of glutamic acid, cysteine and glycine.
The global Reduced Glutathione (GSH) Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Reduced Glutathione (GSH) Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Reduced Glutathione (GSH) Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Reduced Glutathione (GSH) Drugs include Chongqing Yaoyou, Shanghai Fudan Fuhua Pharmaceutical, Italy Sid Pharmaceutical Factory, Kunming Jida and Lvye Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Reduced Glutathione (GSH) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Reduced Glutathione (GSH) Drugs.
Report Scope
The Reduced Glutathione (GSH) Drugs market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Reduced Glutathione (GSH) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Reduced Glutathione (GSH) Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chongqing Yaoyou
Shanghai Fudan Fuhua Pharmaceutical
Italy Sid Pharmaceutical Factory
Kunming Jida
Lvye Pharma
Segment by Type
Tablet
Injection
Other
Segment by Application
Anemia
Asthma
Cataract
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Reduced Glutathione (GSH) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Reduced Glutathione (GSH) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Reduced glutathione is a peptide naturally synthesized in human cytoplasm, composed of glutamic acid, cysteine and glycine.
The global Reduced Glutathione (GSH) Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Reduced Glutathione (GSH) Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Reduced Glutathione (GSH) Drugs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Reduced Glutathione (GSH) Drugs include Chongqing Yaoyou, Shanghai Fudan Fuhua Pharmaceutical, Italy Sid Pharmaceutical Factory, Kunming Jida and Lvye Pharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Reduced Glutathione (GSH) Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Reduced Glutathione (GSH) Drugs.
Report Scope
The Reduced Glutathione (GSH) Drugs market size, estimations, and forecasts are provided in terms of sales volume (KG) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Reduced Glutathione (GSH) Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Reduced Glutathione (GSH) Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Chongqing Yaoyou
Shanghai Fudan Fuhua Pharmaceutical
Italy Sid Pharmaceutical Factory
Kunming Jida
Lvye Pharma
Segment by Type
Tablet
Injection
Other
Segment by Application
Anemia
Asthma
Cataract
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Reduced Glutathione (GSH) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Reduced Glutathione (GSH) Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Reduced Glutathione (GSH) Drugs Market Overview
1.1 Product Overview and Scope of Reduced Glutathione (GSH) Drugs
1.2 Reduced Glutathione (GSH) Drugs Segment by Type
1.2.1 Global Reduced Glutathione (GSH) Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Tablet
1.2.3 Injection
1.2.4 Other
1.3 Reduced Glutathione (GSH) Drugs Segment by Application
1.3.1 Global Reduced Glutathione (GSH) Drugs Market Value by Application: (2024-2030)
1.3.2 Anemia
1.3.3 Asthma
1.3.4 Cataract
1.3.5 Other
1.4 Global Reduced Glutathione (GSH) Drugs Market Size Estimates and Forecasts
1.4.1 Global Reduced Glutathione (GSH) Drugs Revenue 2019-2030
1.4.2 Global Reduced Glutathione (GSH) Drugs Sales 2019-2030
1.4.3 Global Reduced Glutathione (GSH) Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Reduced Glutathione (GSH) Drugs Market Competition by Manufacturers
2.1 Global Reduced Glutathione (GSH) Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Reduced Glutathione (GSH) Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Reduced Glutathione (GSH) Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Reduced Glutathione (GSH) Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Reduced Glutathione (GSH) Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Reduced Glutathione (GSH) Drugs, Product Type & Application
2.7 Reduced Glutathione (GSH) Drugs Market Competitive Situation and Trends
2.7.1 Reduced Glutathione (GSH) Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Reduced Glutathione (GSH) Drugs Players Market Share by Revenue
2.7.3 Global Reduced Glutathione (GSH) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Reduced Glutathione (GSH) Drugs Retrospective Market Scenario by Region
3.1 Global Reduced Glutathione (GSH) Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Reduced Glutathione (GSH) Drugs Global Reduced Glutathione (GSH) Drugs Sales by Region: 2019-2030
3.2.1 Global Reduced Glutathione (GSH) Drugs Sales by Region: 2019-2024
3.2.2 Global Reduced Glutathione (GSH) Drugs Sales by Region: 2025-2030
3.3 Global Reduced Glutathione (GSH) Drugs Global Reduced Glutathione (GSH) Drugs Revenue by Region: 2019-2030
3.3.1 Global Reduced Glutathione (GSH) Drugs Revenue by Region: 2019-2024
3.3.2 Global Reduced Glutathione (GSH) Drugs Revenue by Region: 2025-2030
3.4 North America Reduced Glutathione (GSH) Drugs Market Facts & Figures by Country
3.4.1 North America Reduced Glutathione (GSH) Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Reduced Glutathione (GSH) Drugs Sales by Country (2019-2030)
3.4.3 North America Reduced Glutathione (GSH) Drugs Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Reduced Glutathione (GSH) Drugs Market Facts & Figures by Country
3.5.1 Europe Reduced Glutathione (GSH) Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Reduced Glutathione (GSH) Drugs Sales by Country (2019-2030)
3.5.3 Europe Reduced Glutathione (GSH) Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Reduced Glutathione (GSH) Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Reduced Glutathione (GSH) Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Reduced Glutathione (GSH) Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Reduced Glutathione (GSH) Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Reduced Glutathione (GSH) Drugs Market Facts & Figures by Country
3.7.1 Latin America Reduced Glutathione (GSH) Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Reduced Glutathione (GSH) Drugs Sales by Country (2019-2030)
3.7.3 Latin America Reduced Glutathione (GSH) Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Reduced Glutathione (GSH) Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Reduced Glutathione (GSH) Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Reduced Glutathione (GSH) Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Reduced Glutathione (GSH) Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Reduced Glutathione (GSH) Drugs Sales by Type (2019-2030)
4.1.1 Global Reduced Glutathione (GSH) Drugs Sales by Type (2019-2024)
4.1.2 Global Reduced Glutathione (GSH) Drugs Sales by Type (2025-2030)
4.1.3 Global Reduced Glutathione (GSH) Drugs Sales Market Share by Type (2019-2030)
4.2 Global Reduced Glutathione (GSH) Drugs Revenue by Type (2019-2030)
4.2.1 Global Reduced Glutathione (GSH) Drugs Revenue by Type (2019-2024)
4.2.2 Global Reduced Glutathione (GSH) Drugs Revenue by Type (2025-2030)
4.2.3 Global Reduced Glutathione (GSH) Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Reduced Glutathione (GSH) Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Reduced Glutathione (GSH) Drugs Sales by Application (2019-2030)
5.1.1 Global Reduced Glutathione (GSH) Drugs Sales by Application (2019-2024)
5.1.2 Global Reduced Glutathione (GSH) Drugs Sales by Application (2025-2030)
5.1.3 Global Reduced Glutathione (GSH) Drugs Sales Market Share by Application (2019-2030)
5.2 Global Reduced Glutathione (GSH) Drugs Revenue by Application (2019-2030)
5.2.1 Global Reduced Glutathione (GSH) Drugs Revenue by Application (2019-2024)
5.2.2 Global Reduced Glutathione (GSH) Drugs Revenue by Application (2025-2030)
5.2.3 Global Reduced Glutathione (GSH) Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Reduced Glutathione (GSH) Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Chongqing Yaoyou
6.1.1 Chongqing Yaoyou Corporation Information
6.1.2 Chongqing Yaoyou Description and Business Overview
6.1.3 Chongqing Yaoyou Reduced Glutathione (GSH) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Chongqing Yaoyou Reduced Glutathione (GSH) Drugs Product Portfolio
6.1.5 Chongqing Yaoyou Recent Developments/Updates
6.2 Shanghai Fudan Fuhua Pharmaceutical
6.2.1 Shanghai Fudan Fuhua Pharmaceutical Corporation Information
6.2.2 Shanghai Fudan Fuhua Pharmaceutical Description and Business Overview
6.2.3 Shanghai Fudan Fuhua Pharmaceutical Reduced Glutathione (GSH) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Shanghai Fudan Fuhua Pharmaceutical Reduced Glutathione (GSH) Drugs Product Portfolio
6.2.5 Shanghai Fudan Fuhua Pharmaceutical Recent Developments/Updates
6.3 Italy Sid Pharmaceutical Factory
6.3.1 Italy Sid Pharmaceutical Factory Corporation Information
6.3.2 Italy Sid Pharmaceutical Factory Description and Business Overview
6.3.3 Italy Sid Pharmaceutical Factory Reduced Glutathione (GSH) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Italy Sid Pharmaceutical Factory Reduced Glutathione (GSH) Drugs Product Portfolio
6.3.5 Italy Sid Pharmaceutical Factory Recent Developments/Updates
6.4 Kunming Jida
6.4.1 Kunming Jida Corporation Information
6.4.2 Kunming Jida Description and Business Overview
6.4.3 Kunming Jida Reduced Glutathione (GSH) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Kunming Jida Reduced Glutathione (GSH) Drugs Product Portfolio
6.4.5 Kunming Jida Recent Developments/Updates
6.5 Lvye Pharma
6.5.1 Lvye Pharma Corporation Information
6.5.2 Lvye Pharma Description and Business Overview
6.5.3 Lvye Pharma Reduced Glutathione (GSH) Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Lvye Pharma Reduced Glutathione (GSH) Drugs Product Portfolio
6.5.5 Lvye Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Reduced Glutathione (GSH) Drugs Industry Chain Analysis
7.2 Reduced Glutathione (GSH) Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Reduced Glutathione (GSH) Drugs Production Mode & Process
7.4 Reduced Glutathione (GSH) Drugs Sales and Marketing
7.4.1 Reduced Glutathione (GSH) Drugs Sales Channels
7.4.2 Reduced Glutathione (GSH) Drugs Distributors
7.5 Reduced Glutathione (GSH) Drugs Customers
8 Reduced Glutathione (GSH) Drugs Market Dynamics
8.1 Reduced Glutathione (GSH) Drugs Industry Trends
8.2 Reduced Glutathione (GSH) Drugs Market Drivers
8.3 Reduced Glutathione (GSH) Drugs Market Challenges
8.4 Reduced Glutathione (GSH) Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Reduced Glutathione (GSH) Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Reduced Glutathione (GSH) Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Reduced Glutathione (GSH) Drugs Market Competitive Situation by Manufacturers in 2023
Table 4. Global Reduced Glutathione (GSH) Drugs Sales (KG) of Key Manufacturers (2019-2024)
Table 5. Global Reduced Glutathione (GSH) Drugs Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Reduced Glutathione (GSH) Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Reduced Glutathione (GSH) Drugs Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Reduced Glutathione (GSH) Drugs Average Price (US$/G) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Reduced Glutathione (GSH) Drugs, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Reduced Glutathione (GSH) Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Reduced Glutathione (GSH) Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Reduced Glutathione (GSH) Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Reduced Glutathione (GSH) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Reduced Glutathione (GSH) Drugs as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Reduced Glutathione (GSH) Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Reduced Glutathione (GSH) Drugs Sales by Region (2019-2024) & (KG)
Table 18. Global Reduced Glutathione (GSH) Drugs Sales Market Share by Region (2019-2024)
Table 19. Global Reduced Glutathione (GSH) Drugs Sales by Region (2025-2030) & (KG)
Table 20. Global Reduced Glutathione (GSH) Drugs Sales Market Share by Region (2025-2030)
Table 21. Global Reduced Glutathione (GSH) Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Reduced Glutathione (GSH) Drugs Revenue Market Share by Region (2019-2024)
Table 23. Global Reduced Glutathione (GSH) Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Reduced Glutathione (GSH) Drugs Revenue Market Share by Region (2025-2030)
Table 25. North America Reduced Glutathione (GSH) Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Reduced Glutathione (GSH) Drugs Sales by Country (2019-2024) & (KG)
Table 27. North America Reduced Glutathione (GSH) Drugs Sales by Country (2025-2030) & (KG)
Table 28. North America Reduced Glutathione (GSH) Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Reduced Glutathione (GSH) Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Reduced Glutathione (GSH) Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Reduced Glutathione (GSH) Drugs Sales by Country (2019-2024) & (KG)
Table 32. Europe Reduced Glutathione (GSH) Drugs Sales by Country (2025-2030) & (KG)
Table 33. Europe Reduced Glutathione (GSH) Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Reduced Glutathione (GSH) Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Reduced Glutathione (GSH) Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Reduced Glutathione (GSH) Drugs Sales by Region (2019-2024) & (KG)
Table 37. Asia Pacific Reduced Glutathione (GSH) Drugs Sales by Region (2025-2030) & (KG)
Table 38. Asia Pacific Reduced Glutathione (GSH) Drugs Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Reduced Glutathione (GSH) Drugs Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Reduced Glutathione (GSH) Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Reduced Glutathione (GSH) Drugs Sales by Country (2019-2024) & (KG)
Table 42. Latin America Reduced Glutathione (GSH) Drugs Sales by Country (2025-2030) & (KG)
Table 43. Latin America Reduced Glutathione (GSH) Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Reduced Glutathione (GSH) Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Reduced Glutathione (GSH) Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Reduced Glutathione (GSH) Drugs Sales by Country (2019-2024) & (KG)
Table 47. Middle East & Africa Reduced Glutathione (GSH) Drugs Sales by Country (2025-2030) & (KG)
Table 48. Middle East & Africa Reduced Glutathione (GSH) Drugs Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Reduced Glutathione (GSH) Drugs Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Reduced Glutathione (GSH) Drugs Sales (KG) by Type (2019-2024)
Table 51. Global Reduced Glutathione (GSH) Drugs Sales (KG) by Type (2025-2030)
Table 52. Global Reduced Glutathione (GSH) Drugs Sales Market Share by Type (2019-2024)
Table 53. Global Reduced Glutathione (GSH) Drugs Sales Market Share by Type (2025-2030)
Table 54. Global Reduced Glutathione (GSH) Drugs Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Reduced Glutathione (GSH) Drugs Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Reduced Glutathione (GSH) Drugs Revenue Market Share by Type (2019-2024)
Table 57. Global Reduced Glutathione (GSH) Drugs Revenue Market Share by Type (2025-2030)
Table 58. Global Reduced Glutathione (GSH) Drugs Price (US$/G) by Type (2019-2024)
Table 59. Global Reduced Glutathione (GSH) Drugs Price (US$/G) by Type (2025-2030)
Table 60. Global Reduced Glutathione (GSH) Drugs Sales (KG) by Application (2019-2024)
Table 61. Global Reduced Glutathione (GSH) Drugs Sales (KG) by Application (2025-2030)
Table 62. Global Reduced Glutathione (GSH) Drugs Sales Market Share by Application (2019-2024)
Table 63. Global Reduced Glutathione (GSH) Drugs Sales Market Share by Application (2025-2030)
Table 64. Global Reduced Glutathione (GSH) Drugs Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Reduced Glutathione (GSH) Drugs Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Reduced Glutathione (GSH) Drugs Revenue Market Share by Application (2019-2024)
Table 67. Global Reduced Glutathione (GSH) Drugs Revenue Market Share by Application (2025-2030)
Table 68. Global Reduced Glutathione (GSH) Drugs Price (US$/G) by Application (2019-2024)
Table 69. Global Reduced Glutathione (GSH) Drugs Price (US$/G) by Application (2025-2030)
Table 70. Chongqing Yaoyou Corporation Information
Table 71. Chongqing Yaoyou Description and Business Overview
Table 72. Chongqing Yaoyou Reduced Glutathione (GSH) Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 73. Chongqing Yaoyou Reduced Glutathione (GSH) Drugs Product
Table 74. Chongqing Yaoyou Recent Developments/Updates
Table 75. Shanghai Fudan Fuhua Pharmaceutical Corporation Information
Table 76. Shanghai Fudan Fuhua Pharmaceutical Description and Business Overview
Table 77. Shanghai Fudan Fuhua Pharmaceutical Reduced Glutathione (GSH) Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 78. Shanghai Fudan Fuhua Pharmaceutical Reduced Glutathione (GSH) Drugs Product
Table 79. Shanghai Fudan Fuhua Pharmaceutical Recent Developments/Updates
Table 80. Italy Sid Pharmaceutical Factory Corporation Information
Table 81. Italy Sid Pharmaceutical Factory Description and Business Overview
Table 82. Italy Sid Pharmaceutical Factory Reduced Glutathione (GSH) Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 83. Italy Sid Pharmaceutical Factory Reduced Glutathione (GSH) Drugs Product
Table 84. Italy Sid Pharmaceutical Factory Recent Developments/Updates
Table 85. Kunming Jida Corporation Information
Table 86. Kunming Jida Description and Business Overview
Table 87. Kunming Jida Reduced Glutathione (GSH) Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 88. Kunming Jida Reduced Glutathione (GSH) Drugs Product
Table 89. Kunming Jida Recent Developments/Updates
Table 90. Lvye Pharma Corporation Information
Table 91. Lvye Pharma Description and Business Overview
Table 92. Lvye Pharma Reduced Glutathione (GSH) Drugs Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2019-2024)
Table 93. Lvye Pharma Reduced Glutathione (GSH) Drugs Product
Table 94. Lvye Pharma Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Reduced Glutathione (GSH) Drugs Distributors List
Table 98. Reduced Glutathione (GSH) Drugs Customers List
Table 99. Reduced Glutathione (GSH) Drugs Market Trends
Table 100. Reduced Glutathione (GSH) Drugs Market Drivers
Table 101. Reduced Glutathione (GSH) Drugs Market Challenges
Table 102. Reduced Glutathione (GSH) Drugs Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Reduced Glutathione (GSH) Drugs
Figure 2. Global Reduced Glutathione (GSH) Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Reduced Glutathione (GSH) Drugs Market Share by Type in 2023 & 2030
Figure 4. Tablet Product Picture
Figure 5. Injection Product Picture
Figure 6. Other Product Picture
Figure 7. Global Reduced Glutathione (GSH) Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Reduced Glutathione (GSH) Drugs Market Share by Application in 2023 & 2030
Figure 9. Anemia
Figure 10. Asthma
Figure 11. Cataract
Figure 12. Other
Figure 13. Global Reduced Glutathione (GSH) Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Reduced Glutathione (GSH) Drugs Market Size (2019-2030) & (US$ Million)
Figure 15. Global Reduced Glutathione (GSH) Drugs Sales (2019-2030) & (KG)
Figure 16. Global Reduced Glutathione (GSH) Drugs Average Price (US$/G) & (2019-2030)
Figure 17. Reduced Glutathione (GSH) Drugs Report Years Considered
Figure 18. Reduced Glutathione (GSH) Drugs Sales Share by Manufacturers in 2023
Figure 19. Global Reduced Glutathione (GSH) Drugs Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Reduced Glutathione (GSH) Drugs Players: Market Share by Revenue in 2023
Figure 21. Reduced Glutathione (GSH) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Reduced Glutathione (GSH) Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Reduced Glutathione (GSH) Drugs Sales Market Share by Country (2019-2030)
Figure 24. North America Reduced Glutathione (GSH) Drugs Revenue Market Share by Country (2019-2030)
Figure 25. United States Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Reduced Glutathione (GSH) Drugs Sales Market Share by Country (2019-2030)
Figure 28. Europe Reduced Glutathione (GSH) Drugs Revenue Market Share by Country (2019-2030)
Figure 29. Germany Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Reduced Glutathione (GSH) Drugs Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Reduced Glutathione (GSH) Drugs Revenue Market Share by Region (2019-2030)
Figure 36. China Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Reduced Glutathione (GSH) Drugs Sales Market Share by Country (2019-2030)
Figure 46. Latin America Reduced Glutathione (GSH) Drugs Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Reduced Glutathione (GSH) Drugs Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Reduced Glutathione (GSH) Drugs Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Reduced Glutathione (GSH) Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Reduced Glutathione (GSH) Drugs by Type (2019-2030)
Figure 56. Global Revenue Market Share of Reduced Glutathione (GSH) Drugs by Type (2019-2030)
Figure 57. Global Reduced Glutathione (GSH) Drugs Price (US$/G) by Type (2019-2030)
Figure 58. Global Sales Market Share of Reduced Glutathione (GSH) Drugs by Application (2019-2030)
Figure 59. Global Revenue Market Share of Reduced Glutathione (GSH) Drugs by Application (2019-2030)
Figure 60. Global Reduced Glutathione (GSH) Drugs Price (US$/G) by Application (2019-2030)
Figure 61. Reduced Glutathione (GSH) Drugs Value Chain
Figure 62. Reduced Glutathione (GSH) Drugs Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
